CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions-Reference-Cited by-同舟云学术

CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions

Published:2018-04-06 Issue:12 Volume:124 Page:2607-2620
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

McClain Kenneth L.¹,Picarsic Jennifer²,Chakraborty Rikhia¹,Zinn Daniel¹,Lin Howard¹,Abhyankar Harshal¹,Scull Brooks¹,Shih Albert¹,Lim Karen Phaik Har¹³,Eckstein Olive¹,Lubega Joseph¹,Peters Tricia L.¹⁴,Olea Walter¹,Burke Thomas¹,Ahmed Nabil¹,Hicks M. John¹⁴,Tran Brandon⁵,Jones Jeremy⁵,Dauser Robert⁶,Jeng Michael⁷,Baiocchi Robert⁸,Schiff Deborah⁹,Goldman Stanton¹⁰,Heym Kenneth M.¹¹,Wilson Harry¹²,Carcamo Benjamin¹³,Kumar Ashish¹⁴,Rodriguez-Galindo Carlos¹⁵,Whipple Nicholas S.¹⁵,Campbell Patrick¹⁵,Murdoch Geoffrey¹⁶,Kofler Julia¹⁶,Heales Simon¹⁷,Malone Marian¹⁸,Woltjer Randy¹⁹,Quinn Joseph F.¹⁹,Orchard Paul²⁰,Kruer Michael C.²¹,Jaffe Ronald²²,Manz Markus G.²³,Lira Sergio A.²⁴,Parsons D. Williams¹²⁵,Merad Miriam²⁶,Man Tsz-Kwong¹,Allen Carl E.¹^ORCID

Affiliation:

1. Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine; Houston Texas

2. Department of Pathology; University of Pittsburgh School of Medicine; Pittsburgh Pennsylvania

3. Graduate Program in Translational Biology and Molecular Medicine; Baylor College of Medicine; Houston Texas

4. Department of Pathology; Baylor College of Medicine; Houston Texas

5. Department of Radiology; Baylor College of Medicine; Houston Texas

6. Department of Neurosurgery; Baylor College of Medicine; Houston Texas

7. Department of Pediatrics; Stanford University School of Medicine; Palo Alto California

8. Department of Internal Medicine; The Ohio State University; Columbus Ohio

9. Department of Pediatrics; University of California-San Diego; La Jolla California

10. Medical City Children's Hospital, Dallas Texas and Texas Oncology; Pennsylvania

11. Department of Pediatrics; Cook Children's Medical Center; Fort Worth Texas

12. Department of Pathology; Texas Tech University Health Sciences Center El Paso; El Paso Texas

13. Department of Pediatrics; Texas Tech University Health Sciences Center El Paso; El Paso Texas

14. Cancer and Blood Diseases Institute; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio

15. St. Jude Children's Research Hospital; Memphis Tennessee

16. Department of Pathology, Division of Neuropathology; University of Pittsburgh School of Medicine; Pittsburgh Pennsylvania

17. Chemical Pathology; Great Ormond Street Hospital for Children; London UK

18. Laboratory Medicine; Great Ormond Street Hospital for Children; London UK

19. Layton Aging and Alzheimer's Disease Center; Oregon Health and Science University; Portland Oregon

20. Department of Pediatrics; University of Minnesota; Minneapolis Minnesota

21. Barrow Neurological Institute, Phoenix Children's Hospital; Child Health, Neurology & Genetics; University of Arizona College of Medicine; Phoenix Arizona

22. Department of Pathology, Magee-Women's Hospital of UPMC; University of Pittsburgh School of Medicine; Pittsburgh Pennsylvania

23. Division of Hematology, University of Zurich; University Hospital Zurich; Zurich Switzerland

24. Immunology Institute; Icahn School of Medicine; New York New York

25. Department of Molecular and Human Genetics; Baylor College of Medicine; Houston Texas

26. Department of Oncological Sciences, Tisch Cancer Institute; Icahn School of Medicine; New York New York

Funder

HistioCure Foundation

National Institutes of Health

NIH SPORE in Lymphoma

Alex's Lemonade Stand Foundation for Childhood Cancer

American Society of Hematology Scholar Award

Stand Up to Cancer-St. Baldrick's Pediatric Dream Team Translational Research Grant

St. Baldrick's Foundation

North American Consortium for Histiocytosis Research

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference40 articles.

1. Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases;Berres;Adv.Immunol.,2013

2. Recurrent BRAF mutations in Langerhans cell histiocytosis;Badalian-Very;Blood.,2010

3. Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis;Chakraborty;Blood,2016

4. Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study;Donadieu;J Pediatr.,2004

5. Risk factors for diabetes insipidus in Langerhans cell histiocytosis;Grois;Pediatr Blood Cancer.,2006

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium;Blood Neoplasia;2024-09

2. Clinical features and outcomes of 17 children with systemic juvenile xanthogranuloma (sJXG) including five complicated with hemophagocytic lymphohistiocytosis (HLH);Annals of Hematology;2024-08-23

3. A multidisciplinary non-invasive approach to monitor response to intravenous immunoglobulin treatment in neurodegenerative Langerhans cell histiocytosis: a real-world study;Frontiers in Immunology;2024-08-16

4. Mechanism of neurodegeneration mediated by clonal inflammatory microglia;2024-07-31

5. Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAF^V600E clone in a newborn affected by high‐risk Langerhans cell histiocytosis;British Journal of Haematology;2024-07-10